Mepride 4 Tablet contains Glimepiride 4mg, an oral hypoglycemic agent belonging to the sulfonylurea class, indicated for the management of type 2 diabetes mellitus. It functions by stimulating pancreatic beta cells to release insulin, thereby improving glycemic control in patients whose hyperglycemia cannot be managed by diet and exercise alone. Mepride 4 is typically prescribed as part of a comprehensive diabetes treatment plan, which may include dietary modifications, physical activity, and other antidiabetic medications. The tablet is administered once daily, preferably with breakfast or the first main meal, to optimize efficacy and minimize the risk of hypoglycemia. Caution is advised in patients with hepatic or renal impairment, as dosage adjustments may be necessary. Common adverse effects include hypoglycemia, weight gain, gastrointestinal disturbances, and hypersensitivity reactions. Monitoring of blood glucose levels is essential to avoid hypoglycemic episodes, especially in elderly patients or those with irregular meal patterns. Mepride 4 should be used with caution in combination with other antidiabetic agents to prevent additive hypoglycemic effects. It is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, and those with known hypersensitivity to sulfonylureas. Regular follow-up and patient education are critical to ensure safe and effective therapy.

Dosage & How to Use